Photo taken from Chiara Corti/X
Jun 4, 2024, 12:43
Chiara Corti: DESTINY-Breast06 results presented by G Curigliano
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“DESTINY-Breast06 results presented by G Curigliano.
T-DXd showed efficacy also as 1st line cytotoxic agent in HR and HER2low (n=713) and UltraLow (n=153) mBC. 11% ILD (3 g5).”
Source: Chiara Corti/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 20:46
Apr 21, 2025, 20:30
Apr 21, 2025, 20:11
Apr 21, 2025, 19:55
Apr 21, 2025, 19:12
Apr 21, 2025, 18:19
Apr 21, 2025, 18:00
Apr 21, 2025, 17:40
Apr 21, 2025, 17:35
Apr 21, 2025, 17:29